IP Library Granted Patent US 11,137,391
Granted Patent B2
US 11,137,391 · App. 15/952,966 · Granted Oct 5, 2021

Modular point-of-care devices, systems, and uses thereof

Inventors: Tammy Burd (Palo Alto, CA); Ian Gibbons (Newark, CA); Elizabeth A. Holmes (Palo Alto, CA); Gary Frenzel (Palo Alto, CA); Anthony Joseph Nugent (Palo Alto, CA)
Assignee: Labrador Diagnostics LLC
G01N33/5304A61B5/15A61B5/151A61B5/150755B01J19/0046B01L3/0262B01L3/5025B01L3/527B01L7/52B01L9/543G01N1/38G01N33/5302G01N33/54326G01N33/54366G01N33/54386G01N33/56966G01N33/57484G01N33/6803G01N33/94G01N35/00732G01N35/00871G01N35/028G01N35/10G01N35/1065G01N35/1074G16H10/40A61B10/007A61B10/0038A61B10/0045A61B10/0051A61B10/0058A61B10/02A61B2010/0074A61B2010/0077B01J2219/005B01J2219/00283B01J2219/00292B01J2219/00315B01J2219/00369B01J2219/00371B01J2219/00385B01J2219/00466B01J2219/00495B01J2219/00693B01J2219/00702B01L3/021B01L7/5255B01L2200/04B01L2200/0689B01L2200/141B01L2200/148B01L2300/0654B01L2300/0829B01L2300/1805B01L2400/043G01N2035/0097G01N2035/00237G01N2035/00851G01N2035/00881G01N2035/1032G01N2035/1034G01N2035/1048G01N2333/475G01N2333/4737G01N2333/71G01N2333/912G01N2333/9129G01N2333/91205G01N2800/26G01N2800/60Y10T29/49826Y10T436/25375
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,137,391
App. No.
15/952,966
Granted
Oct 5, 2021
Kind
B2
Abstract

The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.

Claims (36)

1. A point-of-care system for detecting an analyte in a biological sample, the system comprising:

a cartridge comprising:

a plurality of addressable reagent units configured to contain cartridge reagents for running reactions for detecting the analyte; and

a sample unit configured to receive the biological sample;

an assay unit configured to receive the biological sample from the sample unit and the cartridge reagents from the plurality of addressable reagent units, wherein the assay unit comprises a reaction site having thereon an immobilized binding reagent that is configured to yield a signal indicative of the presence of the analyte in the biological sample;

a fluid transfer device coupled to the assay unit and comprising a programmable processor, wherein the fluid transfer device is configured to draw the biological sample and at least one of the cartridge reagents into the assay unit and into contact with the reaction site according to a protocol corresponding to the analyte, wherein the protocol comprises:

instructions for moving the assay unit to a location of the sample unit and to locations of one or more of the plurality of addressable reagent units;

a sequence for transferring the biological sample and the cartridge reagents to the assay unit; and

an amount of each of the biological sample and the cartridge reagents to transfer to the assay unit; and

a detection assembly configured to detect an intensity of the signal indicative of the presence of the analyte.

2. The system of claim 1 , wherein the biological sample includes blood, serum, plasma, saliva, urine, tears, gastric fluid, digestive fluid, bone marrow, cerebrospinal fluid, stool, semen, vaginal fluid, or liquid extracted from tissue.

3. The system of claim 1 , wherein the binding reagent includes an antibody, a nucleic acid probe, or a cell membrane receptor.

4. The system of claim 1 , wherein each of the cartridge reagents includes a conjugate reagent, a wash buffer, a wash solution, a detergent, a polymer, a chelating agent, an albumin-binding reagent, an anticoagulant, an enzyme substrate, a sample diluent, or a detector conjugate.

5. The system of claim 1 , wherein the detection assembly includes a photodiode, an avalanche photodiode, a photomultiplier (PMT), a photon counting detector, or a charge-coupled device.

6. The system of claim 1 , wherein the fluid transfer device is configured to direct the fluid transfer according to an aspiration-type action, a pipette-type action, a capillary-type action, or a controlled pumping.

7. The system of claim 1 , wherein the protocol includes an instruction for transferring the biological sample and the cartridge reagents to the assay unit based on a predetermined address indicating a location of the assay unit.

8. The system of claim 1 , further comprising a communication assembly configured to transmit the signal as detected by the detection assembly to an external device.

9. The system of claim 1 , wherein the biological sample and the cartridge reagents are transferred to the assay unit in an order and a combination based on the protocol.

10. The system of claim 1 , further comprising a patient station display having a touchscreen.

11. The system of claim 1 , wherein the reaction site of the assay unit is located on an interior surface of the assay unit.

12. The system of claim 1 , wherein the reaction site is one of a plurality of reaction sites of the assay unit, and wherein each reaction site of the plurality of reaction sites comprises a different immobilized binding reagent.

13. The system of claim 1 , wherein the analyte includes one of a drug, prodrug, pharmaceutical agent, drug metabolite, antibody, cholesterol, polysaccharide, lipid, nucleic acid, biomarker, gene, polypeptide, protein, or hormone.

14. A system for detecting an analyte in a biological sample, comprising:

a cartridge comprising:

a plurality of addressable reagent units configured to contain cartridge reagents for running reactions for detecting the analyte; and

a sample unit configured to receive the biological sample;

an assay unit configured to receive the biological sample from the sample unit and the cartridge reagents from the plurality of addressable reagent units, wherein the assay unit comprises a reaction site having thereon an immobilized binding reagent that is configured to yield an optical signal indicative of the presence of the analyte in the biological sample;

a reader assembly configured to receive the cartridge and the assay unit to perform an assay to detect the analyte, the reader assembly comprising:

a fluid transfer device configured to be coupled to the assay unit and comprising a programmable processor, wherein the fluid transfer device is configured to draw the biological sample and the cartridge reagents into the assay unit and into contact with the reaction site according to a protocol corresponding to the analyte, wherein the protocol comprises instructions for moving the assay unit to a location of the sample unit and to a location of one or more of the plurality of addressable reagent units, a sequence for transferring the biological sample and the cartridge reagents to the assay unit, and an amount of each of the biological sample and the cartridge reagents to transfer to the assay unit; and

a detection assembly configured to detect the optical signal indicative of the presence of the analyte.

15. The system of claim 14 , wherein the biological sample includes blood, serum, plasma, saliva, urine, tears, gastric fluid, digestive fluid, bone marrow, cerebrospinal fluid, stool, semen, vaginal fluid, or liquid extracted from tissue.

16. The system of claim 14 , wherein the binding reagent includes an antibody, a nucleic acid probe, or a cell membrane receptor.

17. The system of claim 14 , wherein each of the cartridge reagents includes a conjugate reagent, a wash buffer, a wash solution, a detergent, a polymer, a chelating agent, an albumin-binding reagent, an anticoagulant, an enzyme substrate, a sample diluent, or a detector conjugate.

18. The system of claim 14 , wherein the detection assembly includes a photodiode, an avalanche photodiode, a photomultiplier (PMT), a photon counting detector, or a charge-coupled device.

19. The system of claim 14 , wherein the protocol includes an instruction for transferring the sample and the cartridge reagents to the assay unit based at least in part on a predetermined address indicating a location of the assay unit.

20. The device of claim 14 , wherein the reader assembly further comprises a communication assembly in wireless communication with an external device for transmitting the optical signal to the external device.

Assignments (1)
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
Continuity (8)
Continuation 14872718 · Oct 2, 2015
Continuation 14670200 · Mar 26, 2015
Continuation 13893258 · May 13, 2013
Continuation 13889674 · May 8, 2013
Continuation 13326023 · Dec 14, 2011
Continuation 12244723 · Oct 2, 2008
Provisional Application 60997460 · Oct 2, 2007
Related Publication 20180238864A1 · Aug 23, 2018